SECTOR GAMMA AS Q1 2022 holdings

$460 Million is the total value of SECTOR GAMMA AS's 40 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 33.3% .

 Value Shares↓ Weighting
MRK BuyMERCK & CO INC$40,955
+12.3%
499,141
+4.9%
8.90%
+3.8%
GILD BuyGILEAD SCIENCES INC$40,517
+87.8%
681,538
+129.4%
8.80%
+73.6%
INCY BuyINCYTE CORP$35,105
+26.2%
442,012
+16.7%
7.63%
+16.7%
BMY SellBRISTOL-MYERS SQUIBB CO$24,360
+12.1%
333,558
-4.3%
5.29%
+3.6%
MDT BuyMEDTRONIC PLC$22,856
+8.2%
206,006
+0.9%
4.97%
-0.0%
CAH SellCARDINAL HEALTH INC$21,391
-16.4%
377,270
-24.0%
4.65%
-22.7%
CVS SellCVS HEALTH CORP$20,128
-5.4%
198,873
-3.5%
4.37%
-12.5%
BSX SellBOSTON SCIENTIFIC CORP$17,509
-17.5%
395,335
-20.9%
3.80%
-23.7%
BIIB BuyBIOGEN INC$17,258
+8.0%
81,945
+23.0%
3.75%
-0.2%
CNC BuyCENTENE CORP DEL$16,389
+8.6%
194,664
+6.3%
3.56%
+0.4%
BRKR BuyBRUKER CORP$16,201
+18.6%
251,952
+54.8%
3.52%
+9.7%
NUVA BuyNUVASIVE INC$15,084
+19.4%
266,035
+10.5%
3.28%
+10.4%
ANTM SellANTHEM INC$14,254
-10.6%
29,018
-15.7%
3.10%
-17.4%
CI BuyCIGNA CORP NEW$13,986
+46.8%
58,370
+40.7%
3.04%
+35.7%
OGN SellORGANON & CO$11,867
-9.7%
339,738
-21.3%
2.58%
-16.5%
QGEN BuyQIAGEN NV$10,742
-1.8%
219,226
+11.4%
2.33%
-9.3%
ALNY NewALNYLAM PHARMACEUTICALS INC$9,67559,251
+100.0%
2.10%
ELAN BuyELANCO ANIMAL HEALTH INC$9,515
-2.9%
364,691
+5.6%
2.07%
-10.2%
ZBH NewZIMMER BIOMET HOLDINGS INC$8,28864,801
+100.0%
1.80%
AZN NewASTRAZENECA PLCsponsored adr$8,226124,000
+100.0%
1.79%
BIO BuyBIO RAD LABS INCcl a$7,201
-18.1%
12,785
+9.8%
1.56%
-24.3%
IONS SellIONIS PHARMACEUTICALS INC$6,980
+9.5%
188,439
-10.1%
1.52%
+1.2%
BDX SellBECTON DICKINSON & CO$6,978
-63.3%
26,233
-65.3%
1.52%
-66.1%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$6,880
+17.3%
47,467
+4.9%
1.50%
+8.4%
PFE SellPFIZER INC$6,717
-60.1%
129,738
-54.5%
1.46%
-63.1%
VRTX SellVERTEX PHARMACEUTICALS INC$6,461
-24.7%
24,758
-36.6%
1.40%
-30.4%
BMRN SellBIOMARIN PHARMACEUTICAL INC$6,149
-38.7%
79,759
-29.8%
1.34%
-43.3%
ITCI NewINTRA-CELLULAR THERAPIES INC$4,94780,843
+100.0%
1.08%
RIGL SellRIGEL PHARMACEUTICALS INC$4,385
+12.6%
1,466,678
-0.2%
0.95%
+4.2%
PDCO BuyPATTERSON COS INC$4,200
+16.4%
129,757
+5.5%
0.91%
+7.7%
SAGE BuySAGE THERAPEUTICS INC$3,922
-6.8%
118,476
+19.8%
0.85%
-13.9%
RARE NewULTRAGENYX PHARMACEUTICAL IN$3,35746,221
+100.0%
0.73%
PTCT NewPTC THERAPEUTICS INC$2,98079,864
+100.0%
0.65%
NVAX BuyNOVAVAX INC$2,823
+47.9%
38,324
+187.2%
0.61%
+36.5%
XRAY SellDENTSPLY SIRONA INC$2,732
-57.4%
55,516
-51.6%
0.59%
-60.6%
QTRX NewQUANTERIX CORP$2,58888,670
+100.0%
0.56%
NewSOMALOGIC INC$2,416301,224
+100.0%
0.52%
VIR BuyVIR BIOTECHNOLOGY INC$2,063
+12.0%
80,223
+82.3%
0.45%
+3.5%
ATRA NewATARA BIOTHERAPEUTICS INC$1,149123,713
+100.0%
0.25%
MRTX SellMIRATI THERAPEUTICS INC$976
-74.5%
11,875
-54.5%
0.21%
-76.4%
BNTX ExitBIONTECH SEsponsored ads$0-13,032
-100.0%
-0.79%
LH ExitLABORATORY CORP AMER HLDGS$0-23,377
-100.0%
-1.73%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Janicke Forde — Head of fund operations

Compare quarterly holdings

Export SECTOR GAMMA AS's holdings

EDGAR filings